Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
cladosporium herbarum
- Development stage
- Unknown
- Lead developer
- Inmunotek
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Intradermal, Subcutaneous, Percutaneous, Sublingual, Inhalation, Intranasal
01
Overview
*Cladosporium herbarum* is a common filamentous fungus (mold) whose extract is utilized in clinical medicine as a biologic agent for the diagnosis and treatment of allergic respiratory diseases. As a significant aeroallergen, it is a frequent cause of fungal sensitization in patients with bronchial asthma and allergic rhinitis. In diagnostic settings, the allergen extract is used in skin prick tests (SPT) to identify specific IgE-mediated sensitivity. Therapeutically, it is employed in allergy immunotherapy (AIT), where it is administered in gradually increasing doses to induce immune tolerance and reduce the severity of allergic symptoms. Beyond its clinical use, *Cladosporium herbarum* is studied for its role in environmental health and its potential applications in bioremediation, such as the degradation of fungicides like imazalil in industrial effluents.
- Other names
- Cladosporium herbarum allergen extract
02
Targets
A. annua-specific IgE (Artemisia annua-specific immunoglobulin E)
Beyond the preview
Go deeper on cladosporium herbarum.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on cladosporium herbarum.